Literature DB >> 1124500

Hemodynamics within a canine femoral arteriovenous fistula.

J E Lavigne, C S Brown, J Fewel, K G Swan.   

Abstract

Blood flow and pressures around a canine femoral arteriovenous fistula, constructed from an autogenous carotid artery, were measured to determine the pressure-flow relationships within the fistula, as well as to determine the presence or absence of retrograde flow in the distal artery and vein. The findings indicate that retrograde arterial flow occurs only when the proximal femoral artery is occluded and, even then, the contribution to fistula flow is small and well below control femoral arterial flow. Retrograde distal venous flow is negligible. Pressure within the fistula is high at the arterial end but is rapidly dissipated across the loop fistula to equal systemic venous pressure on the venous side. Modest distal venous hypertension accompanies this type of fistula. For these reasons, a loop-type, arteriovenous fistula is preferable to other types of fistulas for most clinical surgical indications.

Entities:  

Mesh:

Year:  1975        PMID: 1124500

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  4 in total

1.  Surgical technique for creation of an arteriovenous fistula using a looped bovine graft.

Authors:  E A Lefrak; G P Noon
Journal:  Ann Surg       Date:  1975-12       Impact factor: 12.969

2.  Effect of arteriovenous fistula on wound healing and skin blood flow.

Authors:  H Takiff; M L Owens; R A Williams
Journal:  Br J Exp Pathol       Date:  1984-12

3.  Experience with dacron graft arteriovenous fistulas for dialysis access.

Authors:  J F Burdick; W Scott; A B Cosimi
Journal:  Ann Surg       Date:  1978-03       Impact factor: 12.969

4.  Acute portal hypertension models in dogs: low- and high-flow approaches.

Authors:  Jaydev K Dave; Ji-Bin Liu; Valgerdur G Halldorsdottir; John R Eisenbrey; Daniel A Merton; Priscilla Machado; Hongjia Zhao; Joseph Altemus; Laurence Needleman; Daniel B Brown; Flemming Forsberg
Journal:  Comp Med       Date:  2012-10       Impact factor: 0.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.